0000899243-22-007203.txt : 20220222 0000899243-22-007203.hdr.sgml : 20220222 20220222165108 ACCESSION NUMBER: 0000899243-22-007203 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220217 FILED AS OF DATE: 20220222 DATE AS OF CHANGE: 20220222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ALTSHULER DAVID CENTRAL INDEX KEY: 0001550395 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 22658997 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-17 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001550395 ALTSHULER DAVID C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, Global Research and CSO Common Stock 2022-02-17 4 F 0 3439 232.51 D 53999 D Common Stock 2022-02-18 4 S 0 986 229.22 D 53013 D Common Stock 2022-02-18 4 S 0 1303 230.05 D 51710 D Common Stock 2022-02-18 4 S 0 385 231.01 D 51325 D Common Stock 2022-02-18 4 S 0 600 231.85 D 50725 D Common Stock 2022-02-18 4 S 0 1038 233.27 D 49687 D Transaction made pursuant to Mr. Altshuler's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $229.22 (range $228.65 to $229.60). Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $230.05 (range $229.65 to $230.59). Open market sales reported on this line occurred at a weighted average price of $231.01 (range $230.66 to $231.43). Open market sales reported on this line occurred at a weighted average price of $231.85 (range $231.67 to $232.01). Open market sales reported on this line occurred at a weighted average price of $233.27 (range $232.91 to $233.50). /s/ Sabrina Yohai, Attorney-in-Fact 2022-02-22